Sabang, Rosita T.

HRN: 04-74-90  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2023
CEFTRIAXONE 1G (VIAL)
12/20/2023
12/26/2023
IV
1 Gram
Q 12 Hrs
Uti
Checking Final Appropriateness 
12/26/2023
CIPROFLOXACIN 500MG (TAB)
12/26/2023
01/01/2024
PO
500MG
OD
UTI
Checking Final Appropriateness 
12/20/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/20/2024
12/27/2024
IV
4.5gm
Q6h
CELLULUTIS
Waiting Final Action 
12/20/2024
CLINDAMYCIN 300MG (CAP)
12/20/2024
12/27/2024
PO
600mg
Q8h
CELLULUTIS
Waiting Final Action 
12/25/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/25/2024
01/01/2025
IV
600mg
Q8h
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: